News

Oral remibrutinib demonstrates significant relapse reduction compared with teriflunomide in relapsing multiple sclerosis across twin Phase 3 trials.

Adding pembrolizumab to chemotherapy extends progression-free survival in advanced breast cancer after any prior endocrine therapy.

Early antibiotic discontinuation in febrile neutropenia reduced antibiotic exposure without increasing severe outcomes in interim trial findings.

ICU alarm fatigue may be reduced by targeting brief ventilator alerts, which accounted for nearly 80% of events.

Growth hormone secretagogues raise physiological growth factors, demanding vigilant clinical evaluation regarding potential oncologic risks.

A Phase II/III Ebola vaccine trial has begun in Congo as the Bundibugyo outbreak approaches 4,800 deaths

Combined cigarette and biomass smoke exposure was associated with worse COPD outcomes, including more severe exacerbations.

A nationwide cohort study demonstrates that post-acute neuromuscular conditions and long-term neurocognitive effects attenuate within one year.